Momentum Is Strong For Elanco Animal Health Inc (NYSE: ELAN)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

Stocks Info

This NYSE-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. The current market capitalization of Elanco Animal Health Inc is $5.36B. A total of 3.46 million shares were traded on the day, compared to an average of 4.60M shares.

In the most recent transaction, Kurzius Lawrence Erik bought 10,000 shares of ELAN for 10.90 per share on Mar 07 ’25. After the transaction, the Director now owns 101,459 company shares. In a previous transaction on Mar 11 ’25, Kurzius Lawrence Erik bought 10,000 shares at 10.20 per share. ELAN shares that Director owns now total 111,459.

Among the insiders who bought shares, HOOVER R DAVID acquired of 25,000 shares on Mar 05 ’25 at a per-share price of $10.90. This resulted in the Director holding 210,000 shares of ELAN after the transaction. In another insider transaction, Harrington Michael J bought 3,500 shares at $14.85 per share on Aug 22 ’24. Company shares held by the Director now total 81,094.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ELAN has a high of $18.80 and a low of $10.03.

As of this writing, ELAN has an earnings estimate of $0.31 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $0.32 per share and a lower estimate of $0.29.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ELAN’s latest balance sheet shows that the firm has $638.00M in Cash & Short Term Investments as of fiscal 2021. There were $6.32B in debt and $1.65B in liabilities at the time. Its Book Value Per Share was $12.33, while its Total Shareholder’s Equity was $7.51B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ELAN is Buy with a score of 4.09.

Most Popular

Related Posts